Cargando…
Effect of DPP4/CD26 expression on SARS-CoV-2 susceptibility, immune response, adenosine (derivatives m(6)(2)A and CD) regulations on patients with cancer and healthy individuals
The worldwide COVID-19 pandemic was brought on by a new coronavirus (SARS Cov-2). A marker/receptor called Dipeptidyl peptidase 4/CD26(DPP4/CD26) may be crucial in determining susceptibility to tumors and coronaviruses. However, the regulation of DPP4 in COVID-invaded cancer patients and its role on...
Autores principales: | Du, Jiaman, Fu, Jiewen, Zhang, Wenqian, Zhang, Lianmei, Chen, Hanchun, Cheng, Jingliang, He, Tao, Fu, Junjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946808/ https://www.ncbi.nlm.nih.gov/pubmed/36799191 http://dx.doi.org/10.3892/ijo.2023.5489 |
Ejemplares similares
-
Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2
por: Fu, Jiewen, et al.
Publicado: (2022) -
COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2
por: Li, Dabing, et al.
Publicado: (2021) -
Prostate adenocarcinoma and COVID‐19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS‐CoV‐2
por: Cheng, Jingliang, et al.
Publicado: (2021) -
COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2
por: Zhang, Lianmei, et al.
Publicado: (2022) -
Impact of BSG/CD147 gene expression on diagnostic, prognostic and therapeutic strategies towards malignant cancers and possible susceptibility to SARS-CoV-2
por: Fu, Jiewen, et al.
Publicado: (2022)